Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Participants needed: 36
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Kang Stem Biotech Co., Ltd.Updated: Aug 10, 2026Locations: 2
Eligibility criteria

Participants who received placebo in the K0701 clinical trial and completed the... [+1]

Participants whom the investigator considers unsuitable for participation in thi... [+1]

Status: Not yet recruiting

Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study

Long-Term Follow-up Study of Subjects with Knee Osteoarthritis who had administered FURESTEM-OA Kit Inj. in K0701 study

Participants needed: 58
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Kang Stem Biotech Co., Ltd.Updated: Aug 30, 2023
Eligibility criteria

Those who participated in the K0701 clinical trial and received PureStem-OA Kit... [+1]

None

Status: Not yet recruiting

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

A multi-center, open, long-term follow-up study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results from the K0104 Extension Study

Participants needed: 102
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Kang Stem Biotech Co., Ltd.Updated: Jan 29, 2021Locations: 1
Eligibility criteria

Subject who enrolled K0104 Clinical Trial(parent study). [+1]

Subjects who are expected to be unable to perform at least one follow-up during... [+2]